SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Dirk Müller, Lisa Borsi, Claudia Stracke, Stephanie Stock, Björn Stollenwerk, Cost-effectiveness of a multifactorial fracture prevention program for elderly people admitted to nursing homes, The European Journal of Health Economics, 2014,

    CrossRef

  2. 2
    Olivier Bruyère, Jean-Yves Reginster, Monitoring of osteoporosis therapy, Best Practice & Research Clinical Endocrinology & Metabolism, 2014,

    CrossRef

  3. 3
    Margaret A. Paggiosi, Richard Eastell, Jennifer S. Walsh, Precision of High-Resolution Peripheral Quantitative Computed Tomography Measurement Variables: Influence of Gender, Examination Site, and Age, Calcified Tissue International, 2014, 94, 2, 191

    CrossRef

  4. 4
    Anna Capozzi, Stefano Lello, Alfredo Pontecorvi, The inhibition of RANK-ligand in the management of postmenopausal osteoporosis and related fractures: the role of denosumab, Gynecological Endocrinology, 2014, 30, 6, 403

    CrossRef

  5. 5
    Matthew R. Allen, Christopher L. Newman, Eric Smith, Drew M. Brown, Jason M. Organ, Variability of in vivo reference point indentation in skeletally mature inbred rats, Journal of Biomechanics, 2014, 47, 10, 2504

    CrossRef

  6. 6
    Matthew R. Allen, Kelly Krohn, Basic and Applied Bone Biology, 2014,

    CrossRef

  7. 7
    Michelle L Frost, Amelia E Moore, Musib Siddique, Glen M Blake, Didier Laurent, Babul Borah, Ursula Schramm, Marie-Anne Valentin, Theodore C Pellas, Paul K Marsden, Paul J Schleyer, Ignac Fogelman, 18F-fluoride PET as a noninvasive imaging biomarker for determining treatment efficacy of bone active agents at the hip: A prospective, randomized, controlled clinical study, Journal of Bone and Mineral Research, 2013, 28, 6
  8. 8
    Lucía Silva-Fernández, María Piedad Rosario, Juan Antonio Martínez-López, Loreto Carmona, Estibaliz Loza, Denosumab for the treatment of osteoporosis: A systematic literature review, Reumatología Clínica (English Edition), 2013, 9, 1, 42

    CrossRef

  9. 9
    Lucía Silva-Fernández, María Piedad Rosario, Juan Antonio Martínez-López, Loreto Carmona, Estibaliz Loza, Denosumab for the treatment of osteoporosis: A systematic literature review, Reumatología Clínica, 2013, 9, 1, 42

    CrossRef

  10. 10
    Jan de Vries, Jean-Michel Antoine, Tomasz Burzykowski, Alessandro Chiodini, Mike Gibney, Gunter Kuhnle, Agnès Méheust, Loek Pijls, Ian Rowland, Markers for nutrition studies: review of criteria for the evaluation of markers, European Journal of Nutrition, 2013, 52, 7, 1685

    CrossRef

  11. 11
    Kim Naylor, Richard Eastell, Bone turnover markers: use in osteoporosis, Nature Reviews Rheumatology, 2012, 8, 7, 379

    CrossRef

  12. 12
    G.M. Treece, K.E.S. Poole, A.H. Gee, Imaging the femoral cortex: Thickness, density and mass from clinical CT, Medical Image Analysis, 2012, 16, 5, 952

    CrossRef

  13. 13
    V. Rabenda, O. Bruyère, J.-Y. Reginster, Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression, Osteoporosis International, 2011, 22, 3, 893

    CrossRef

  14. 14
    Itsuo Gorai, Yaku Tanaka, Shin Hattori, Yasuhisa Iwaoki, Assessment of adherence to treatment of postmenopausal osteoporosis with raloxifene and/or alfacalcidol in postmenopausal Japanese women, Journal of Bone and Mineral Metabolism, 2010, 28, 2, 176

    CrossRef

  15. 15
    E. Michael Lewiecki, Benefits and Limitations of Bone Mineral Density and Bone Turnover Markers to Monitor Patients Treated for Osteoporosis, Current Osteoporosis Reports, 2010, 8, 1, 15

    CrossRef

  16. 16
    George P. Lyritis, Thomas Georgoulas, Christos P Zafeiris, Bone anabolic versus bone anticatabolic treatment of postmenopausal osteoporosis, Annals of the New York Academy of Sciences, 2010, 1205, 1
  17. 17
    E. Michael Lewiecki, Bone Densitometry and Vertebral Fracture Assessment, Current Osteoporosis Reports, 2010, 8, 3, 123

    CrossRef

  18. 18
    Sarah L. Manske, Heather M. Macdonald, Kyle K. Nishiyama, Steven K. Boyd, Heather A. McKay, Clinical Tools to Evaluate Bone Strength, Clinical Reviews in Bone and Mineral Metabolism, 2010, 8, 3, 122

    CrossRef

  19. 19
    David L Kendler, Christian Roux, Claude Laurent Benhamou, Jacques P Brown, Michael Lillestol, Suresh Siddhanti, Hoi-Shen Man, Javier San Martin, Henry G Bone, Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy, Journal of Bone and Mineral Research, 2010, 25, 1
  20. 20
    Xiutao Shi, X. Sherry Liu, Xiang Wang, X. Edward Guo, Glen L. Niebur, Effects of trabecular type and orientation on microdamage susceptibility in trabecular bone, Bone, 2010, 46, 5, 1260

    CrossRef

  21. 21
    E. Michael Lewiecki, Fracture Risk Assessment in Clinical Practice: T-scores, FRAX, and Beyond, Clinical Reviews in Bone and Mineral Metabolism, 2010, 8, 3, 101

    CrossRef

  22. 22
    G.M. Treece, A.H. Gee, P.M. Mayhew, K.E.S. Poole, High resolution cortical bone thickness measurement from clinical CT data, Medical Image Analysis, 2010, 14, 3, 276

    CrossRef

  23. 23
    E. Michael Lewiecki, Monitoring pharmacological therapy for osteoporosis, Reviews in Endocrine and Metabolic Disorders, 2010, 11, 4, 261

    CrossRef

  24. 24
    Klaus Engelke, Thomas Fuerst, Gorana Dasic, Richard Y. Davies, Harry K. Genant, Regional distribution of spine and hip QCT BMD responses after one year of once-monthly ibandronate in postmenopausal osteoporosis, Bone, 2010, 46, 6, 1626

    CrossRef

  25. 25
    Darren R. Hodgson, Robin D. Whittaker, Athula Herath, Dereck Amakye, Glen Clack, Biomarkers in oncology drug development, Molecular Oncology, 2009, 3, 1, 24

    CrossRef

  26. 26
    Steven R. Cummings, Javier San Martin, Michael R. McClung, Ethel S. Siris, Richard Eastell, Ian R. Reid, Pierre Delmas, Holly B. Zoog, Matt Austin, Andrea Wang, Stepan Kutilek, Silvano Adami, Jose Zanchetta, Cesar Libanati, Suresh Siddhanti, Claus Christiansen, Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis, New England Journal of Medicine, 2009, 361, 8, 756

    CrossRef

  27. 27
    Paul D. Miller, Diagnosis and Treatment of Osteoporosis in Chronic Renal Disease, Seminars in Nephrology, 2009, 29, 2, 144

    CrossRef

  28. 28
    Jian-Min Liu, Annie Wai-chee Kung, Chan Siew Pheng, Han-Min Zhu, Zhen-Lin Zhang, Yi-Yong Wu, Ling Xu, Xun-Wu Meng, Min-Li Huang, Leung Ping Chung, Nik Hazlina Nik Hussain, Seri Suniza Sufian, Jia-Lun Chen, Efficacy and safety of 2 g/day of strontium ranelate in Asian women with postmenopausal osteoporosis, Bone, 2009, 45, 3, 460

    CrossRef

  29. 29
    Roman S. Lorenc, Heinrich Resch, Management of osteoporosis in central and eastern Europe (CEE): conclusions of the “2nd Summit on Osteoporosis—CEE”, 21–22 November 2008, Warsaw, Poland, Archives of Osteoporosis, 2009, 4, 1-2, 1

    CrossRef

  30. 30
    D. L. Kendler, J. D. Adachi, R. G. Josse, D. O. Slosman, Monitoring strontium ranelate therapy in patients with osteoporosis, Osteoporosis International, 2009, 20, 7, 1101

    CrossRef

  31. 31
    Heather M Macdonald, Maureen C Ashe, Heather A McKay, The link between physical activity and bone strength across the lifespan, International Journal of Clinical Rheumatology, 2009, 4, 4, 437

    CrossRef

  32. 32
    Pawel Szulc, Douglas C. Bauer, Richard Eastell, Biochemical Markers of Bone Turnover in Osteoporosis,